Division of Vascular Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
Division of Cardiovascular and Interventional Radiology, Department of Bioimaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
J Vasc Surg. 2023 Dec;78(6):1383-1391.e5. doi: 10.1016/j.jvs.2023.05.054. Epub 2023 Jun 16.
To assess the early experience with modified version of simplified bare-wire target vessel (SMART) technique, implying delivery of bridging stent grafts without historically established sheath support, and to compare its outcome to standard endovascular aortic repair procedures with fenestrated/branched devices.
A retrospective analysis of 102 consecutive patients treated with fenestrated/branched devices from January 2020 to December 2022 was undertaken. The study population was divided into three groups-a sheath group (SG), SMART group, and nonsheath group (NSG). Primary end points were radiation exposure (dose-area product), fluoroscopy time, dose of contrast agent, operation time, and incidence of intraoperative target vessel (TV) complications and additional procedures. Freedom from secondary TV related reinterventions at the three follow-up phases were defined as secondary end points.
A total of 183 TVs (38.8% visceral arteries [VA]; 56.3% renal arteries [RA]) in the SG, 36 TVs (44.4% VA, 55.6% RA) in the SMART group, and 168 TVs (47.6% VA; 50% RA) in the NSG were accessed. The mean number of fenestrations and bridging stent grafts was equally distributed in all three groups. The SMART group only included cases treated with fenestrated devices. The dose-area product was significantly lower in the SMART (median, 203 Gy × cm; interquartile range [IQR], 179-365 Gy × cm) and NSG (median, 340 Gy × cm; IQR, 220-651 Gy × cm) groups vs the SG (median, 464 Gy × cm; IQR, 267-871 Gy × cm; P = .007). Operation time was also significantly lower in the NSG (median, 265 minutes; IQR, 221-337 minutes) and SMART (median, 292 minutes; IQR, 234-351 minutes) groups vs the SG (median, 326 minutes; IQR, 277-375 minutes; P = .004), respectively. Intraoperative TV-related complications were most frequently observed in the SG (9/183 TVs; P = .008).
This study reports the outcomes of three currently available TV stenting approaches. Previously reported SMART technique, and its modified version (NSG) proved to be a safe alternative to historically established TV stenting technique with sheath support (SG).
评估改良简化裸线靶血管(SMART)技术的早期经验,该技术意味着在没有历史上建立的鞘支持的情况下输送桥接支架移植物,并将其结果与使用开窗/分支装置的标准血管内主动脉修复程序进行比较。
对 2020 年 1 月至 2022 年 12 月期间使用开窗/分支装置治疗的 102 例连续患者进行回顾性分析。研究人群分为三组-鞘组(SG)、SMART 组和无鞘组(NSG)。主要终点是辐射暴露(剂量-面积乘积)、透视时间、造影剂剂量、手术时间以及术中靶血管(TV)并发症和附加程序的发生率。三个随访阶段的无继发性 TV 相关再干预的无失败定义为次要终点。
SG 中有 183 个 TV(38.8%内脏动脉[VA];56.3%肾动脉[RA]),SMART 组中有 36 个 TV(44.4%VA,55.6%RA),NSG 中有 168 个 TV(47.6%VA;50%RA)。三组的平均开窗和桥接支架移植物数量相等。SMART 组仅包括使用开窗装置治疗的病例。SMART 组(中位数 203 Gy×cm;四分位距 [IQR],179-365 Gy×cm)和 NSG 组(中位数 340 Gy×cm;IQR,220-651 Gy×cm)的剂量-面积乘积明显低于 SG 组(中位数 464 Gy×cm;IQR,267-871 Gy×cm;P=0.007)。NSG(中位数 265 分钟;IQR,221-337 分钟)和 SMART 组(中位数 292 分钟;IQR,234-351 分钟)的手术时间也明显低于 SG 组(中位数 326 分钟;IQR,277-375 分钟;P=0.004)。术中 TV 相关并发症最常发生在 SG(183 个 TV 中有 9 个;P=0.008)。
本研究报告了三种目前可用的 TV 支架置入方法的结果。先前报道的 SMART 技术及其改良版(NSG)被证明是一种安全的替代方法,可替代具有鞘支持的历史上建立的 TV 支架置入技术(SG)。